AVADEL PHARMACEUTICALS CVR (ALKERMES PLC merger)
COM · CUSIP G29CVR019
2
institutional holders
+1 vs Q1 2026
2.6m
shares reported held*
$0reported value*
1 new
1 added
0 reduced
0 sold out
net bought ≈ $0 (+1.3m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2026 | 1 |
| Q2 2026 | 2 |
Biggest buyers
| Trium Capital LLP | Added | +1.3m |
| GAMMA Investing LLC | New | +646 |
Biggest sellers
| None |
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Trium Capital LLP 0.00% of their portfolio | 2.6m $0 | Added +1.3m |
| GAMMA Investing LLC 0.00% of their portfolio | 646 $0 | New |